# Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy

> **NCT02446704** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Zofia Piotrowska** · enrollment: 66 (actual)

## Conditions studied

- Small Cell Lung Cancer

## Interventions

- **DRUG:** Olaparib
- **DRUG:** Temozolomide

## Key facts

- **NCT ID:** NCT02446704
- **Lead sponsor:** Zofia Piotrowska
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10-13
- **Primary completion:** 2022-12
- **Final completion:** 2023-12
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2022-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02446704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02446704, "Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02446704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*